2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Common Stock Value | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |
Weighted Average Number Of Diluted Shares Outstanding | 51.54 | NA | NA | 12.20 | 12.18 | |
Weighted Average Number Of Shares Outstanding Basic | 51.54 | NA | 12.20 | 12.20 | 12.18 | |
Earnings Per Share Basic | -2.51 | -4.22 | -0.36 | -0.46 | -0.35 | |
Earnings Per Share Diluted | -2.51 | -4.22 | -0.36 | -0.46 | -0.35 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Revenue From Contract With Customer Excluding Assessed Tax | 1.03 | 3.83 | 3.56 | 4.26 | 2.36 | |
Revenues | 1.03 | 3.83 | 3.56 | 4.26 | 2.36 | |
Operating Expenses | 133.33 | 98.48 | 8.20 | 10.04 | 6.83 | |
Research And Development Expense | 15.37 | 9.64 | 3.82 | 5.72 | 3.91 | |
General And Administrative Expense | 6.00 | 8.04 | 4.38 | 4.32 | 2.92 | |
Operating Income Loss | -132.30 | -94.65 | -4.63 | -5.77 | -4.47 | |
Interest Income Expense Net | 2.81 | 2.02 | 0.29 | 0.22 | 0.20 | |
Allocated Share Based Compensation Expense | 2.16 | 2.88 | 1.08 | 1.03 | 1.22 | |
Profit Loss | -129.49 | -92.63 | -4.34 | -5.56 | -4.27 | |
Net Income Loss | -129.49 | -92.63 | -4.34 | -5.56 | -4.27 | |
Comprehensive Income Net Of Tax | -129.51 | NA | NA | NA | -4.27 | |
Net Income Loss Available To Common Stockholders Basic | -129.49 | -92.63 | -4.34 | NA | -4.27 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Assets | 319.75 | 148.54 | 93.16 | 41.44 | 48.11 | |
Liabilities | 34.18 | 28.66 | 87.08 | 32.10 | 34.25 | |
Liabilities And Stockholders Equity | 319.75 | 148.54 | 93.16 | 41.44 | 48.11 | |
Stockholders Equity | 285.57 | 119.88 | 6.08 | 9.34 | 13.86 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Assets Current | 313.33 | 144.70 | 91.41 | 39.53 | 46.54 | |
Cash And Cash Equivalents At Carrying Value | 269.72 | 98.68 | 90.64 | 38.42 | 44.42 | |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 269.82 | 98.78 | 90.74 | 38.52 | 44.52 | |
Prepaid Expense And Other Assets Current | 3.62 | 6.56 | 0.77 | 1.11 | 2.11 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Property Plant And Equipment Net | 4.30 | 2.07 | 1.17 | 1.20 | 0.92 | |
Other Assets Noncurrent | 0.57 | 0.10 | NA | NA | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Liabilities Current | 30.77 | 21.83 | 23.11 | 26.39 | 24.83 | |
Accounts Payable Current | 7.18 | 3.31 | 2.79 | 3.70 | 3.31 | |
Other Accrued Liabilities Current | 0.42 | 0.31 | 0.25 | 0.49 | 0.24 | |
Other Liabilities Current | 0.06 | 0.20 | 0.54 | NA | NA | |
Contract With Customer Liability Current | 12.74 | 10.49 | 16.96 | 17.67 | 18.21 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Deferred Income Tax Liabilities Net | NA | 0.38 | NA | NA | NA | |
Other Liabilities Noncurrent | NA | 1.34 | 0.12 | NA | NA | |
Operating Lease Liability Noncurrent | 1.21 | 1.34 | NA | NA | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Stockholders Equity | 285.57 | 119.88 | 6.08 | 9.34 | 13.86 | |
Common Stock Value | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |
Additional Paid In Capital | 637.86 | 342.66 | 136.25 | 135.16 | 134.13 | |
Retained Earnings Accumulated Deficit | -352.30 | -222.81 | -130.17 | -125.83 | -120.27 | |
Accumulated Other Comprehensive Income Loss Net Of Tax | 0.00 | 0.02 | NA | NA | NA | |
Stock Issued During Period Value New Issues | NA | 0.00 | 0.00 | 0.00 | 0.22 | |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2.16 | 2.88 | 1.07 | 1.00 | 1.20 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -11.17 | -17.46 | -8.61 | -5.67 | 24.17 | |
Net Cash Provided By Used In Investing Activities | -37.23 | -30.00 | -0.04 | -0.34 | -0.11 | |
Net Cash Provided By Used In Financing Activities | 219.44 | 55.50 | 60.88 | 0.00 | 0.03 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -11.17 | -17.46 | -8.61 | -5.67 | 24.17 | |
Net Income Loss | -129.49 | -92.63 | -4.34 | -5.56 | -4.27 | |
Profit Loss | -129.49 | -92.63 | -4.34 | -5.56 | -4.27 | |
Depreciation Depletion And Amortization | 0.16 | 0.15 | 0.11 | 0.10 | 0.09 | |
Increase Decrease In Accounts Payable | 2.40 | -0.68 | -1.21 | 0.59 | 0.69 | |
Share Based Compensation | 2.16 | 2.88 | 1.08 | 1.03 | 1.22 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Net Cash Provided By Used In Investing Activities | -37.23 | -30.00 | -0.04 | -0.34 | -0.11 | |
Payments To Acquire Property Plant And Equipment | 2.16 | 0.35 | 0.04 | 0.34 | 0.11 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Net Cash Provided By Used In Financing Activities | 219.44 | 55.50 | 60.88 | 0.00 | 0.03 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Revenues | 1.03 | 3.83 | 3.56 | 4.26 | 2.36 | |
Collaboration Agreement With Abbvie | 1.00 | 3.80 | 3.60 | 4.30 | 2.40 | |
Revenue From Contract With Customer Excluding Assessed Tax | 1.03 | 3.83 | 3.56 | 4.26 | 2.36 | |
Collaboration Agreement With Abbvie | 1.00 | 3.80 | 3.60 | 4.30 | 2.40 |